Osteoarthritis Treatment Market is segmented by Drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Hyaluronic acid Injection, and Other Drugs), Anatomy (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and OtherAnatomies), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The Osteoarthritis Treatment Market is expected to witness a CAGR of 6.76% over the forecast period, 2021-2028.
Osteoarthritis, also known as degenerative arthritis, is the most commonly occurring chronic condition that affects the joints. This leads to severe joint pain and stiffness of the affected body parts. Osteoarthritis can be treated by several treatments, which include exercise for reducing joint pain, and pain medications.
The rising geriatric population, increasing incidence of osteoarthritis, and rising demand for minimally invasive surgical procedures are some of the factors that have supported long-term expansion for Osteoarthritis Therapeutics Market.
The market for osteoarthritis therapeutics is anticipated to be marginally affected due to the outbreak of COVID-19. Among drug types, the use of corticosteroids has reduced. Although there is no evidence to suggest that corticosteroid injections lead to a substantial increase in the risk of infection, there is a possible reduction in the immune response for up to a few weeks following the procedure.
The North American market is expected to grow, owing to the increasing lifestyle changes, an increasing number of obesity cases, and an extensive rise in the geriatric population in North America. As a result, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among people, government reimbursement policies, and the willingness to take up treatment is expected to add up to the growth of the osteoarthritis treatment market in the region.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 6.76% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
Drugs, anatomy and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Sanofi SA, Pfizer Inc., GlaxoSmithKline plc, Zimmer Biomet, Abbott Laboratories, Bayer AG, and Anika Therapeutics. |
Available Customization |
In addition to the market data for Osteoarthritis Therapeutics Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Osteoarthritis Therapeutics Market is segmented into drugs, anatomy and region.